As the AHA and its members continue to address maternal mortality, the association today voiced support for the Joint Commission’s recently proposed standards for perinatal safety. “Specifically, we support the Joint Commission’s focus on evidence-based procedures and responses that will ensure the most medically appropriate and effective course of treatment for those individuals diagnosed with either maternal hemorrhages or severe hypertension/preeclampsia,” AHA wrote. “In addition, we support the proposed requirement for education of staff, and believe conducting complication-specific training and drills will better prepare providers to act effectively and efficiently when these situations arise. Further, we support the proposed provisions to provide patients and their families with the necessary educational materials to recognize symptoms that require immediate care as another important safeguard in this process.” For more on how hospitals are working to advance better health for mothers and babies, visit https://www.aha.org/better-health-for-mothers-and-babies.

Related News Articles

Headline
The Food and Drug Administration has identified a Class I recall of Abiomed Automated Impella Controllers due to the potential for serious injury or death. The…
Headline
The AHA’s social media toolkit for spreading awareness of the flu focuses on the beginning of fall and the availability of the flu vaccine for at-risk,…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
Lindsey Fauveau, M.D., medical director of breast surgical oncology at Woman’s Hospital, shares how the hospital’s state-of-the-art mobile unit brings 3D…
Headline
The Centers for Disease Control and Prevention Sept. 24 released its annual report on national sexually transmitted disease data, reporting a 9% decline in STD…
Headline
The National Institutes of Health Sept. 16 announced it has launched a consortium to help reduce preventable stillbirths across the U.S. The NIH said…